We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ilika Plc | LSE:IKA | London | Ordinary Share | GB00B608Z994 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 1.67% | 30.50 | 29.00 | 32.00 | 31.25 | 29.50 | 30.00 | 954,686 | 08:31:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 702k | -7.3M | -0.0459 | -6.64 | 48.49M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/5/2022 06:19 | Tell you what sunshine i have a very low tolerance for stupidity so I'll pop you on ignore which seems eminently suitable for your constant negativity. As for IoTs i would say these opportunities are out there still but the medical devices world has engaged more at this stage so are pursuing that avenue. If the batteries are tested in that environment then far easier to then look at a host of other applications.There could be enormous overlap with the automotive world where the company are obviously developing strong relationships around Goliath. Anyway ttfn. | kooba | |
16/5/2022 18:04 | Thanks for heads up..clearly on the interview its stated that the company has been and is supplying for prototypes on devices for a number of years going through approval process so some may be far closer to approval than 3-5 years. | kooba | |
16/5/2022 17:42 | Rgk is thick as 2 short planks as he does exact same posts on other forums under different monikers trying to influence prices. He is just a troll. | jcthatsme10 | |
16/5/2022 17:17 | Are you so thick you can't understand that it will not be the full 3-5 years to get to mass market as products are already advanced through process? | kooba | |
16/5/2022 15:27 | Wasn't my take ..devices can take 3-5 years to get approval but many are already advanced in this process..the battery will power such devices and they will undoubtedly come under scrutiny in terms of reliability and performance however the entire device is not being held up in approval process waiting for consistent quality in battery , i would have thought once the battery is quality approved can be brought into the process fully. I thought the interview was fine ..pretty clear and feel the opportunity relative to current valuation is attractive. Been out for a while because it all got a bit ahead of itself when the US battery CO's went ballistic but interesting here and reasonable level of funding in place , so back in a few today. | kooba | |
16/5/2022 14:39 | You put exact same post on LSE, give the link for GPs interview and stop your misinformation. | jcthatsme10 | |
16/5/2022 09:41 | https://www.director | kooba | |
14/5/2022 13:55 | Phil2003 isn’t that technology even further behind than Ilika . I’d certainly agree if it’s perfected it would be a game changer and I daresay the shares would reflect that. | sworks4me | |
13/5/2022 10:35 | .. And how their offering is better than using a self charging micro battery (cells which create electricity from air borne humidity / the skin surface to self-charge within minutes. (ie: no manual charging or wired power required, ever).. I own shares in such a company. | phil2003 | |
13/5/2022 10:25 | The major market for these is surely not in-body devices, of which there are few eg pacemakers, insulin pumps etc, but smart watches etc, of which there are very many. The company needs to be clearer about which markets its targeting, and how it expects to win business. 'Medical' covers a very wide range of possible applications. | supernumerary | |
13/5/2022 09:24 | Kenjen, you’re wrong, no brand owner is gonna buy a battery from a manufacturer (specifically for medical use) without FDA approval, if they love it they might agree to part fund the approval process but that’d be very rare.. all the risk is with the manufacturer until the tech is approved as safe then one brand owner jumps onboard, then others follow. | phil2003 | |
13/5/2022 08:59 | Then again I’m sitting on a loss so maybe it’s me that’s got the problem :) | kenjen1 | |
13/5/2022 08:53 | Guys ffs! It’s the OEM’s that have to get the approval not the battery company. The product owners get the approval that covers all components of their product. Not approval for each component part!!! I thought you guys were bright! | kenjen1 | |
13/5/2022 08:47 | Was I wrong to predict 65 p for IKA in Nov 21 .But some bought it for 165 so I withdrew to avoid negative feeling in my Dear Colleagues. So its there, not yet out of woods.20/30 | chillu | |
13/5/2022 08:11 | I don't see why they couldn't produce a 99.99% reliable battery, however the testing regimes for in-body medical kit takes ages. No good testing them in rats. They don't live long enough for a proper trial. | horneblower | |
13/5/2022 08:09 | FDA only work to their own process & glacial timings, I had a meeting with them and the MRHA (for a ftse 100) on their own turf and it was like 1940’s Germany… new tech approval will take years. | phil2003 | |
12/5/2022 23:18 | CEO expects to announce further Goliath collaborations over the coming months. He would not be saying that unless things fairly well advanced. Hopefully a further update with the results. | robertspc1 | |
12/5/2022 17:26 | Over the years...dozens. | horneblower | |
12/5/2022 17:25 | Rolled out today by our majority shareholders demand I bet. Either way I don’t think yesterday was as bad as everyone thought. Delays always murder and share price but it will come back, guess it may be a bargain entry point. For some but Im holding, not adding or selling until I see progress or otherwise over the next few months! | kenjen1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions